aluates Reports

$ 0.0

Automative

Global Pet Biopharmaceuticals Market Research Report 2025

Published Date: July 2025

Report Code: QYRE-Auto-13W10453

Global Pet Biopharmaceuticals Market Insights Forecast to 2028

BUY CHAPTERS

Global Pet Biopharmaceuticals Market Research Report 2025

Code: QYRE-Auto-13W10453

Report

July 2025

Pages:90

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Zoetis Inc

Boehringer Ingelheim

Merck

Elanco

Virbac

Dechra Veterinary Products

Ceva

Vetoquinol

Ouro Fino Saude

Norbrook

Jindun

Chopperlvya Animal Health

CAHIC

Pet Biopharmaceuticals Market Size

The global market for Pet Biopharmaceuticals was valued at US$ 15500 million in the year 2024 and is projected to reach a revised size of US$ 21290 million by 2031, growing at a CAGR of 4.7% during the forecast period.

Pet Biopharmaceuticals Market

Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China"s Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China"s pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 47%.

This report aims to provide a comprehensive presentation of the global market for Pet Biopharmaceuticals, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pet Biopharmaceuticals.

The Pet Biopharmaceuticals market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pet Biopharmaceuticals market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Pet Biopharmaceuticals companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Pet Biopharmaceuticals Market Report

Report Metric	Details
Report Name	Pet Biopharmaceuticals Market
Accounted market size in year	US$ 15500 million
Forecasted market size in 2031	US$ 21290 million
CAGR	4.7%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Antiparasitic Biological Products Antibacterial Others
Segment by Application	Prevention Treatment
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Zoetis, Boehringer Ingelheim, Merck, Elanco, Virbac, Dechra Veterinary Products, Ceva, Vetoquinol, Ouro Fino Saude, Norbrook, Jindun, Chopperlvya Animal Health, CAHIC
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pet Biopharmaceuticals company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Pet Biopharmaceuticals Market growing?

Ans: The Pet Biopharmaceuticals Market witnessing a CAGR of 4.7% during the forecast period 2025-2031.

What is the Pet Biopharmaceuticals Market size in 2031?

Ans: The Pet Biopharmaceuticals Market size in 2031 will be US$ 21290 million.

What is the Pet Biopharmaceuticals Market share by region?

Ans: In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China"s pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry.

Who are the main players in the Pet Biopharmaceuticals Market report?

Ans: The main players in the Pet Biopharmaceuticals Market are Zoetis, Boehringer Ingelheim, Merck, Elanco, Virbac, Dechra Veterinary Products, Ceva, Vetoquinol, Ouro Fino Saude, Norbrook, Jindun, Chopperlvya Animal Health, CAHIC

What are the Application segmentation covered in the Pet Biopharmaceuticals Market report?

Ans: The Applications covered in the Pet Biopharmaceuticals Market report are Prevention, Treatment

What are the Type segmentation covered in the Pet Biopharmaceuticals Market report?

Ans: The Types covered in the Pet Biopharmaceuticals Market report are Antiparasitic, Biological Products, Antibacterial, Others

Recommended Reports

Pet Healthcare

Animal Nutrition

Pet Monitoring

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Pet Biopharmaceuticals Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Antiparasitic

1.2.3 Biological Products

1.2.4 Antibacterial

1.2.5 Others

1.3 Market by Application

1.3.1 Global Pet Biopharmaceuticals Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Prevention

1.3.3 Treatment

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Pet Biopharmaceuticals Market Perspective (2020-2031)

2.2 Global Pet Biopharmaceuticals Growth Trends by Region

2.2.1 Global Pet Biopharmaceuticals Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Pet Biopharmaceuticals Historic Market Size by Region (2020-2025)

2.2.3 Pet Biopharmaceuticals Forecasted Market Size by Region (2026-2031)

2.3 Pet Biopharmaceuticals Market Dynamics

2.3.1 Pet Biopharmaceuticals Industry Trends

2.3.2 Pet Biopharmaceuticals Market Drivers

2.3.3 Pet Biopharmaceuticals Market Challenges

2.3.4 Pet Biopharmaceuticals Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Pet Biopharmaceuticals Players by Revenue

3.1.1 Global Top Pet Biopharmaceuticals Players by Revenue (2020-2025)

3.1.2 Global Pet Biopharmaceuticals Revenue Market Share by Players (2020-2025)

3.2 Global Pet Biopharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Pet Biopharmaceuticals Revenue

3.4 Global Pet Biopharmaceuticals Market Concentration Ratio

3.4.1 Global Pet Biopharmaceuticals Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Pet Biopharmaceuticals Revenue in 2024

3.5 Global Key Players of Pet Biopharmaceuticals Head office and Area Served

3.6 Global Key Players of Pet Biopharmaceuticals, Product and Application

3.7 Global Key Players of Pet Biopharmaceuticals, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Pet Biopharmaceuticals Breakdown Data by Type

4.1 Global Pet Biopharmaceuticals Historic Market Size by Type (2020-2025)

4.2 Global Pet Biopharmaceuticals Forecasted Market Size by Type (2026-2031)

5 Pet Biopharmaceuticals Breakdown Data by Application

5.1 Global Pet Biopharmaceuticals Historic Market Size by Application (2020-2025)

5.2 Global Pet Biopharmaceuticals Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Pet Biopharmaceuticals Market Size (2020-2031)

6.2 North America Pet Biopharmaceuticals Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Pet Biopharmaceuticals Market Size by Country (2020-2025)

6.4 North America Pet Biopharmaceuticals Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Pet Biopharmaceuticals Market Size (2020-2031)

7.2 Europe Pet Biopharmaceuticals Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Pet Biopharmaceuticals Market Size by Country (2020-2025)

7.4 Europe Pet Biopharmaceuticals Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Pet Biopharmaceuticals Market Size (2020-2031)

8.2 Asia-Pacific Pet Biopharmaceuticals Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Pet Biopharmaceuticals Market Size by Region (2020-2025)

8.4 Asia-Pacific Pet Biopharmaceuticals Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Pet Biopharmaceuticals Market Size (2020-2031)

9.2 Latin America Pet Biopharmaceuticals Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Pet Biopharmaceuticals Market Size by Country (2020-2025)

9.4 Latin America Pet Biopharmaceuticals Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Pet Biopharmaceuticals Market Size (2020-2031)

10.2 Middle East & Africa Pet Biopharmaceuticals Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Pet Biopharmaceuticals Market Size by Country (2020-2025)

10.4 Middle East & Africa Pet Biopharmaceuticals Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Zoetis

11.1.1 Zoetis Company Details

11.1.2 Zoetis Business Overview

11.1.3 Zoetis Pet Biopharmaceuticals Introduction

11.1.4 Zoetis Revenue in Pet Biopharmaceuticals Business (2020-2025)

11.1.5 Zoetis Recent Development

11.2 Boehringer Ingelheim

11.2.1 Boehringer Ingelheim Company Details

11.2.2 Boehringer Ingelheim Business Overview

11.2.3 Boehringer Ingelheim Pet Biopharmaceuticals Introduction

11.2.4 Boehringer Ingelheim Revenue in Pet Biopharmaceuticals Business (2020-2025)

11.2.5 Boehringer Ingelheim Recent Development

11.3 Merck

11.3.1 Merck Company Details

11.3.2 Merck Business Overview

11.3.3 Merck Pet Biopharmaceuticals Introduction

11.3.4 Merck Revenue in Pet Biopharmaceuticals Business (2020-2025)

11.3.5 Merck Recent Development

11.4 Elanco

11.4.1 Elanco Company Details

11.4.2 Elanco Business Overview

11.4.3 Elanco Pet Biopharmaceuticals Introduction

11.4.4 Elanco Revenue in Pet Biopharmaceuticals Business (2020-2025)

11.4.5 Elanco Recent Development

11.5 Virbac

11.5.1 Virbac Company Details

11.5.2 Virbac Business Overview

11.5.3 Virbac Pet Biopharmaceuticals Introduction

11.5.4 Virbac Revenue in Pet Biopharmaceuticals Business (2020-2025)

11.5.5 Virbac Recent Development

11.6 Dechra Veterinary Products

11.6.1 Dechra Veterinary Products Company Details

11.6.2 Dechra Veterinary Products Business Overview

11.6.3 Dechra Veterinary Products Pet Biopharmaceuticals Introduction

11.6.4 Dechra Veterinary Products Revenue in Pet Biopharmaceuticals Business (2020-2025)

11.6.5 Dechra Veterinary Products Recent Development

11.7 Ceva

11.7.1 Ceva Company Details

11.7.2 Ceva Business Overview

11.7.3 Ceva Pet Biopharmaceuticals Introduction

11.7.4 Ceva Revenue in Pet Biopharmaceuticals Business (2020-2025)

11.7.5 Ceva Recent Development

11.8 Vetoquinol

11.8.1 Vetoquinol Company Details

11.8.2 Vetoquinol Business Overview

11.8.3 Vetoquinol Pet Biopharmaceuticals Introduction

11.8.4 Vetoquinol Revenue in Pet Biopharmaceuticals Business (2020-2025)

11.8.5 Vetoquinol Recent Development

11.9 Ouro Fino Saude

11.9.1 Ouro Fino Saude Company Details

11.9.2 Ouro Fino Saude Business Overview

11.9.3 Ouro Fino Saude Pet Biopharmaceuticals Introduction

11.9.4 Ouro Fino Saude Revenue in Pet Biopharmaceuticals Business (2020-2025)

11.9.5 Ouro Fino Saude Recent Development

11.10 Norbrook

11.10.1 Norbrook Company Details

11.10.2 Norbrook Business Overview

11.10.3 Norbrook Pet Biopharmaceuticals Introduction

11.10.4 Norbrook Revenue in Pet Biopharmaceuticals Business (2020-2025)

11.10.5 Norbrook Recent Development

11.11 Jindun

11.11.1 Jindun Company Details

11.11.2 Jindun Business Overview

11.11.3 Jindun Pet Biopharmaceuticals Introduction

11.11.4 Jindun Revenue in Pet Biopharmaceuticals Business (2020-2025)

11.11.5 Jindun Recent Development

11.12 Chopperlvya Animal Health

11.12.1 Chopperlvya Animal Health Company Details

11.12.2 Chopperlvya Animal Health Business Overview

11.12.3 Chopperlvya Animal Health Pet Biopharmaceuticals Introduction

11.12.4 Chopperlvya Animal Health Revenue in Pet Biopharmaceuticals Business (2020-2025)

11.12.5 Chopperlvya Animal Health Recent Development

11.13 CAHIC

11.13.1 CAHIC Company Details

11.13.2 CAHIC Business Overview

11.13.3 CAHIC Pet Biopharmaceuticals Introduction

11.13.4 CAHIC Revenue in Pet Biopharmaceuticals Business (2020-2025)

11.13.5 CAHIC Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Zoetis Inc

Boehringer Ingelheim

Merck

Elanco

Virbac

Dechra Veterinary Products

Ceva

Vetoquinol

Ouro Fino Saude

Norbrook

Jindun

Chopperlvya Animal Health

CAHIC

List of Tables

Table 1. Global Pet Biopharmaceuticals Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Antiparasitic

Table 3. Key Players of Biological Products

Table 4. Key Players of Antibacterial

Table 5. Key Players of Others

Table 6. Global Pet Biopharmaceuticals Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Pet Biopharmaceuticals Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Pet Biopharmaceuticals Market Size by Region (2020-2025) & (US$ Million)

Table 9. Global Pet Biopharmaceuticals Market Share by Region (2020-2025)

Table 10. Global Pet Biopharmaceuticals Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 11. Global Pet Biopharmaceuticals Market Share by Region (2026-2031)

Table 12. Pet Biopharmaceuticals Market Trends

Table 13. Pet Biopharmaceuticals Market Drivers

Table 14. Pet Biopharmaceuticals Market Challenges

Table 15. Pet Biopharmaceuticals Market Restraints

Table 16. Global Pet Biopharmaceuticals Revenue by Players (2020-2025) & (US$ Million)

Table 17. Global Pet Biopharmaceuticals Market Share by Players (2020-2025)

Table 18. Global Top Pet Biopharmaceuticals Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pet Biopharmaceuticals as of 2024)

Table 19. Ranking of Global Top Pet Biopharmaceuticals Companies by Revenue (US$ Million) in 2024

Table 20. Global 5 Largest Players Market Share by Pet Biopharmaceuticals Revenue (CR5 and HHI) & (2020-2025)

Table 21. Global Key Players of Pet Biopharmaceuticals, Headquarters and Area Served

Table 22. Global Key Players of Pet Biopharmaceuticals, Product and Application

Table 23. Global Key Players of Pet Biopharmaceuticals, Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Pet Biopharmaceuticals Market Size by Type (2020-2025) & (US$ Million)

Table 26. Global Pet Biopharmaceuticals Revenue Market Share by Type (2020-2025)

Table 27. Global Pet Biopharmaceuticals Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 28. Global Pet Biopharmaceuticals Revenue Market Share by Type (2026-2031)

Table 29. Global Pet Biopharmaceuticals Market Size by Application (2020-2025) & (US$ Million)

Table 30. Global Pet Biopharmaceuticals Revenue Market Share by Application (2020-2025)

Table 31. Global Pet Biopharmaceuticals Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 32. Global Pet Biopharmaceuticals Revenue Market Share by Application (2026-2031)

Table 33. North America Pet Biopharmaceuticals Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 34. North America Pet Biopharmaceuticals Market Size by Country (2020-2025) & (US$ Million)

Table 35. North America Pet Biopharmaceuticals Market Size by Country (2026-2031) & (US$ Million)

Table 36. Europe Pet Biopharmaceuticals Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. Europe Pet Biopharmaceuticals Market Size by Country (2020-2025) & (US$ Million)

Table 38. Europe Pet Biopharmaceuticals Market Size by Country (2026-2031) & (US$ Million)

Table 39. Asia-Pacific Pet Biopharmaceuticals Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 40. Asia-Pacific Pet Biopharmaceuticals Market Size by Region (2020-2025) & (US$ Million)

Table 41. Asia-Pacific Pet Biopharmaceuticals Market Size by Region (2026-2031) & (US$ Million)

Table 42. Latin America Pet Biopharmaceuticals Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 43. Latin America Pet Biopharmaceuticals Market Size by Country (2020-2025) & (US$ Million)

Table 44. Latin America Pet Biopharmaceuticals Market Size by Country (2026-2031) & (US$ Million)

Table 45. Middle East & Africa Pet Biopharmaceuticals Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Middle East & Africa Pet Biopharmaceuticals Market Size by Country (2020-2025) & (US$ Million)

Table 47. Middle East & Africa Pet Biopharmaceuticals Market Size by Country (2026-2031) & (US$ Million)

Table 48. Zoetis Company Details

Table 49. Zoetis Business Overview

Table 50. Zoetis Pet Biopharmaceuticals Product

Table 51. Zoetis Revenue in Pet Biopharmaceuticals Business (2020-2025) & (US$ Million)

Table 52. Zoetis Recent Development

Table 53. Boehringer Ingelheim Company Details

Table 54. Boehringer Ingelheim Business Overview

Table 55. Boehringer Ingelheim Pet Biopharmaceuticals Product

Table 56. Boehringer Ingelheim Revenue in Pet Biopharmaceuticals Business (2020-2025) & (US$ Million)

Table 57. Boehringer Ingelheim Recent Development

Table 58. Merck Company Details

Table 59. Merck Business Overview

Table 60. Merck Pet Biopharmaceuticals Product

Table 61. Merck Revenue in Pet Biopharmaceuticals Business (2020-2025) & (US$ Million)

Table 62. Merck Recent Development

Table 63. Elanco Company Details

Table 64. Elanco Business Overview

Table 65. Elanco Pet Biopharmaceuticals Product

Table 66. Elanco Revenue in Pet Biopharmaceuticals Business (2020-2025) & (US$ Million)

Table 67. Elanco Recent Development

Table 68. Virbac Company Details

Table 69. Virbac Business Overview

Table 70. Virbac Pet Biopharmaceuticals Product

Table 71. Virbac Revenue in Pet Biopharmaceuticals Business (2020-2025) & (US$ Million)

Table 72. Virbac Recent Development

Table 73. Dechra Veterinary Products Company Details

Table 74. Dechra Veterinary Products Business Overview

Table 75. Dechra Veterinary Products Pet Biopharmaceuticals Product

Table 76. Dechra Veterinary Products Revenue in Pet Biopharmaceuticals Business (2020-2025) & (US$ Million)

Table 77. Dechra Veterinary Products Recent Development

Table 78. Ceva Company Details

Table 79. Ceva Business Overview

Table 80. Ceva Pet Biopharmaceuticals Product

Table 81. Ceva Revenue in Pet Biopharmaceuticals Business (2020-2025) & (US$ Million)

Table 82. Ceva Recent Development

Table 83. Vetoquinol Company Details

Table 84. Vetoquinol Business Overview

Table 85. Vetoquinol Pet Biopharmaceuticals Product

Table 86. Vetoquinol Revenue in Pet Biopharmaceuticals Business (2020-2025) & (US$ Million)

Table 87. Vetoquinol Recent Development

Table 88. Ouro Fino Saude Company Details

Table 89. Ouro Fino Saude Business Overview

Table 90. Ouro Fino Saude Pet Biopharmaceuticals Product

Table 91. Ouro Fino Saude Revenue in Pet Biopharmaceuticals Business (2020-2025) & (US$ Million)

Table 92. Ouro Fino Saude Recent Development

Table 93. Norbrook Company Details

Table 94. Norbrook Business Overview

Table 95. Norbrook Pet Biopharmaceuticals Product

Table 96. Norbrook Revenue in Pet Biopharmaceuticals Business (2020-2025) & (US$ Million)

Table 97. Norbrook Recent Development

Table 98. Jindun Company Details

Table 99. Jindun Business Overview

Table 100. Jindun Pet Biopharmaceuticals Product

Table 101. Jindun Revenue in Pet Biopharmaceuticals Business (2020-2025) & (US$ Million)

Table 102. Jindun Recent Development

Table 103. Chopperlvya Animal Health Company Details

Table 104. Chopperlvya Animal Health Business Overview

Table 105. Chopperlvya Animal Health Pet Biopharmaceuticals Product

Table 106. Chopperlvya Animal Health Revenue in Pet Biopharmaceuticals Business (2020-2025) & (US$ Million)

Table 107. Chopperlvya Animal Health Recent Development

Table 108. CAHIC Company Details

Table 109. CAHIC Business Overview

Table 110. CAHIC Pet Biopharmaceuticals Product

Table 111. CAHIC Revenue in Pet Biopharmaceuticals Business (2020-2025) & (US$ Million)

Table 112. CAHIC Recent Development

Table 113. Research Programs/Design for This Report

Table 114. Key Data Information from Secondary Sources

Table 115. Key Data Information from Primary Sources

Table 116. Authors List of This Report

List of Figures

Figure 1. Pet Biopharmaceuticals Picture

Figure 2. Global Pet Biopharmaceuticals Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Pet Biopharmaceuticals Market Share by Type: 2024 VS 2031

Figure 4. Antiparasitic Features

Figure 5. Biological Products Features

Figure 6. Antibacterial Features

Figure 7. Others Features

Figure 8. Global Pet Biopharmaceuticals Market Size by Application (2020-2031) & (US$ Million)

Figure 9. Global Pet Biopharmaceuticals Market Share by Application: 2024 VS 2031

Figure 10. Prevention Case Studies

Figure 11. Treatment Case Studies

Figure 12. Pet Biopharmaceuticals Report Years Considered

Figure 13. Global Pet Biopharmaceuticals Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 14. Global Pet Biopharmaceuticals Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Pet Biopharmaceuticals Market Share by Region: 2024 VS 2031

Figure 16. Global Pet Biopharmaceuticals Market Share by Players in 2024

Figure 17. Global Top Pet Biopharmaceuticals Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pet Biopharmaceuticals as of 2024)

Figure 18. The Top 10 and 5 Players Market Share by Pet Biopharmaceuticals Revenue in 2024

Figure 19. North America Pet Biopharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. North America Pet Biopharmaceuticals Market Share by Country (2020-2031)

Figure 21. United States Pet Biopharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Canada Pet Biopharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Pet Biopharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Pet Biopharmaceuticals Market Share by Country (2020-2031)

Figure 25. Germany Pet Biopharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. France Pet Biopharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. U.K. Pet Biopharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Italy Pet Biopharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Russia Pet Biopharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Nordic Countries Pet Biopharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Pet Biopharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Pet Biopharmaceuticals Market Share by Region (2020-2031)

Figure 33. China Pet Biopharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Japan Pet Biopharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. South Korea Pet Biopharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Southeast Asia Pet Biopharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. India Pet Biopharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Australia Pet Biopharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Pet Biopharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Pet Biopharmaceuticals Market Share by Country (2020-2031)

Figure 41. Mexico Pet Biopharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Brazil Pet Biopharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Pet Biopharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Pet Biopharmaceuticals Market Share by Country (2020-2031)

Figure 45. Turkey Pet Biopharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Saudi Arabia Pet Biopharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. UAE Pet Biopharmaceuticals Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Zoetis Revenue Growth Rate in Pet Biopharmaceuticals Business (2020-2025)

Figure 49. Boehringer Ingelheim Revenue Growth Rate in Pet Biopharmaceuticals Business (2020-2025)

Figure 50. Merck Revenue Growth Rate in Pet Biopharmaceuticals Business (2020-2025)

Figure 51. Elanco Revenue Growth Rate in Pet Biopharmaceuticals Business (2020-2025)

Figure 52. Virbac Revenue Growth Rate in Pet Biopharmaceuticals Business (2020-2025)

Figure 53. Dechra Veterinary Products Revenue Growth Rate in Pet Biopharmaceuticals Business (2020-2025)

Figure 54. Ceva Revenue Growth Rate in Pet Biopharmaceuticals Business (2020-2025)

Figure 55. Vetoquinol Revenue Growth Rate in Pet Biopharmaceuticals Business (2020-2025)

Figure 56. Ouro Fino Saude Revenue Growth Rate in Pet Biopharmaceuticals Business (2020-2025)

Figure 57. Norbrook Revenue Growth Rate in Pet Biopharmaceuticals Business (2020-2025)

Figure 58. Jindun Revenue Growth Rate in Pet Biopharmaceuticals Business (2020-2025)

Figure 59. Chopperlvya Animal Health Revenue Growth Rate in Pet Biopharmaceuticals Business (2020-2025)

Figure 60. CAHIC Revenue Growth Rate in Pet Biopharmaceuticals Business (2020-2025)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Animal Pharmaceutical Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Pet Smart Cameras Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Veterinary Biologicals Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Companion Animal Speciality Drugs Market Research Report 2024

Global Insects as Animal Feed Market Insights Forecast to 2030

Pet Food Nutraceutical Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Indoor Pet Training Products Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Dog And Cat Joint Health Supplement Market Research Report 2025

Pet Cat Food and Treats Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Pet Furniture for Home Use Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Pet School Market Research Report 2025

Global Subscription and Fresh Dog Food Market Research Report 2025

Global Pet Body Health Management Product Market Research Report 2025

Veterinary Pain Management Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Dog Vitamin Supplement Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Veterinary Procedure Lights Market Research Report 2024

Global Antibiotics for Dogs and Cats Market Research Report 2025

Pet Oral Care Products Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Veterinary Services Market Research Report 2024

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-14Y6812

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-34O3983

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-9V17601

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-22C17047

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions